SCHEMBL4879792

SCHEMBL4879792

CCn1c(CCO)nc(C(F)(F)F)c1Sc1cc(Cl)cc(C#N)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902728 0.93 ACSS2 (0.32)
SCHEMBL4884136 0.92 SMN1; SMN2 (0.31)
SCHEMBL4882617 0.85 KCNH2 (0.34)
SCHEMBL4877765 0.83 SMN1; SMN2 (0.37)
SCHEMBL4875980 0.82 TSHR (0.33)
SCHEMBL4905168 0.81 TSHR (0.35)
SCHEMBL4896799 0.76 KCNH2 (0.30)
SCHEMBL4887120 0.76 KCNH2 (0.35)
SCHEMBL4902680 0.75 ALDH1A1 (0.35)
SCHEMBL4899905 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176919-A1 Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators PFIZER INC 2008-07-24 US disclosed
US-20080176919-A1 Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators PFIZER INC 2008-07-24 US disclosed
US-20080176919-A1 Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators PFIZER INC 2008-07-24 US disclosed